• Home
  • Search Results

Search Results

2811 studies match your search
Open

ALAMERE - NSI-8226-201

Are you living with eosinophilic esophagitis (EoE)? Consider joining our research study to help advance treatment options for this condition. We invite you to participate in a clinical trial comparing the effects of solrikitug, a potential new medicine, with a placebo. By joining, you'll contribute to understanding the effectiveness and safety of solrikitug in treating EoE. The study aims to evaluate its impact on tissue inflammation, difficulty swallowing, and overall quality of life. Your participation is voluntary, and you can withdraw at any time without losing medical benefits. With approximately 157 participants globally, you'll receive thorough medical monitoring throughout the 72-week study period. Plus, you'll have opportunities to discuss your experience with our team and internationally recognized EoE researcher, Dr. Evan Dellon. Make a difference in EoE research-join us today and be part of the journey towards better treatments for EoE.

Age & Gender
  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Stomach, Digestion and Gut Health
  • Women's Health
  • and 3 more
Open

Career transitions research study

Hi there, we are looking to interview workers who are willing to share their experience of a recent or an ongoing career/work-related transition they've made or are making. The interview - done remotely - should last between 60-90 minutes. Additionally, participants will be asked to complete a brief pre-interview survey that will help us better prepare for the interview itself. Besides helping out with our project, we hope that this interview may provide a chance for you to reflect on the career transition that you've made so far. If you're interested in participating, please complete the screening questions to help us assess fit. Thank you for your time and consideration.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Social or Workplace Dynamics
Visit Location
100% Remote (online, phone, text)
Open

Physical Activity Treatment Study

Do you identify as Black or African-American? Have you been diagnosed with colon cancer, rectal cancer, or colorectal cancer? If so, you may be able to take part in a study to see if an exercise program can help with cancer side effects and overall quality of life. Compensation provided,

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
  • Wellness and Lifestyle
  • Movement
Visit Location
100% Remote (online, phone, text)
Open

Walking Feedback Study

Are you 40 or older, or do you have Parkinson's disease, or have you had a stroke? Can you walk on your own? You might be able to join a research study to see how different types of feedback can help people walk better.

Age & Gender
  • 40 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Healthy Volunteer or General Population
  • Movement
  • and 2 more
Not currently enrolling

19F MRI Healthy vs. CF

Researchers are collecting data on lung imaging to evaluate how well a person's lungs are working which will provide additional information about lung disease and how such diseases respond to treatment. The purpose of this study is to evaluate the use of inert (non-reactive) gas mixed with oxygen as contrast agent to image the airway spaces in normal human lungs and the lungs of persons with cystic fibrosis. A contrast agent helps the investigator to see spaces inside your lungs that are normally not visible. These images will be compared with spirometry (a non-imaging measure of global lung function used routinely in the clinic).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Lungs and Breathing
Coming Soon

Relapsed Peripheral T-cell Lymphoma Treatment Study

In this study, we want to find out if a new drug called Soquelitinib (also known as CPI-818) can be safely given to people. We are also checking to see if it can help treat a type of cancer called relapsed peripheral T-cell lymphoma (PTCL).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Lymphoma)
Coming Soon

IDH-Wildtype Glioblastoma Treatment Study

In this study, we will find out if a new experimental pill called ropidoxuridine can help improve the treatment of a brain cancer called IDH-Wildtype Glioblastoma. We want to see how well it works when used with radiation therapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System)
Open

Trying For Baby Study

Are you planning to become a parent for the first time? Are you married or living with your partner? If so, you may be able to take part in a study on how couples prepare for first-time parenthood. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Sexual and/or Reproductive Health
  • Men's Health
  • and 4 more
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

Suicidal Thoughts and Behaviors Among Elementary School Students

This research study explores elementary school professional experiences and perspectives in assessing and intervening in suicide-related risk among K-5th graders.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Injury/Injury Prevention
  • Mental and Emotional Health
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
Coming Soon

A Phase 1b Study of AMG509 in Subjects w/ High-risk Biochemical Recurrence of Prostate Cancer

This study is being carried out to learn more about administration of xaluritamig in people with high-risk biochemical recurrence (BCR) or sometimes referred to as nonmetastatic castration-sensitive prostate cancer (nmCSPC) after receiving definitive (primary) treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male
Study Interest
  • Cancer (Prostate, Phase 1 Trials (all cancers))
  • Rare Diseases
  • Men's Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research